MeSH tree: D12.776.124.486.485.114.323
Critically ill COVID-19 patients often have antibodies in their blood that bind to the body's own structures, so-called autoantibodies. Scientists from the BIH at Charité and the Max Delbrück Center have now discovered that ...
Apr 4, 2023
0
47
Sometimes in the laboratory there are unexpected results. "Previously it had been observed that autoantibodies are common in severe COVID patients, those who end up in intensive care," says Jonathan Muri, postdoctoral fellow ...
Mar 6, 2023
0
61
In autoimmune encephalitis, a rare but serious and sometimes life-threatening inflammation of the central nervous system, the body's own defenses are directed against the central nervous system. This disease was first identified ...
Mar 3, 2023
0
96
A group of University of Pittsburgh researchers has given new meaning to "knowing your ABCs." In a new study, published in the Journal of Experimental Medicine, the team showed that a type of immune cell called age-associated ...
Mar 2, 2023
0
58
COVID-19 has had a huge global impact since the initial outbreak in 2019. Men and women show different responses to this disease, with men having a higher risk from infection. The underlying cellular basis for this difference ...
Feb 13, 2023
0
89
Researchers from the Institut Pasteur, Inserm, St. James's Hospital Dublin and Trinity are getting closer to understanding what makes some people so vulnerable to COVID-19-induced illness, which in turn may guide the development ...
Dec 1, 2022
0
93
The Geneva University Hospitals (HUG), the University of Geneva (UNIGE) and their spin-off Endotelix have created a possible target molecule for the antibodies responsible for antiphospholipid syndrome. This discovery will ...
Nov 1, 2022
0
23
Since the earliest months of the COVID-19 pandemic, physicians and scientists worldwide have been working to understand how exactly the virus makes us sick. That task, already complicated by COVID's rapid spread, is made ...
Oct 21, 2022
0
77
While there's no cure for lupus and treatments don't work for many of the 1.5 million people who live with the disease in the United States, a new study shows a cancer therapy may kick hard-to-treat lupus into remission.
Sep 15, 2022
0
146
Hundreds of millions of people have had COVID, leaving many with an array of lingering symptoms known as long COVID. Awareness of long COVID has increased, allowing clinicians to refine their approach to diagnosing and treating ...
Sep 13, 2022
0
44
